Jeff Atkinson, DM, PhD, PMP
Chief Executive Officer
Dr. Atkinson manages complex projects and programs in high technology sectors and within numerous functions including IT, Engineering, Operations and Corporate Development. He also has managed over a dozen mergers and acquisitions (M&A) programs from initiation, through diligence and deal work, and integration. He has significant experience working internationally, having managed projects and teams for global companies of all sizes. Dr. Atkinson has been a collegiate instructor, having taught courses in Project Management, IT, business and project management. He holds a Doctor of Management (DM) degree from University of Phoenix, a PhD in Engineering Management from Kennedy Western University, a MS in Technology Management from Mercer University, and a BS in Information Systems from Slippery Rock University.
Glen M. Doniger, PhD
Director of Scientific Development
Dr. Doniger joined NeuroTrax in 2003. A cognitive psychologist, he directs numerous multi-center trials using the NeuroTrax system and is responsible for ensuring the scientific integrity of the NeuroTrax tests and data. Dr. Doniger has worked in cognitive neuroscience research since 1995, utilizing behavioral, event-related potentials, and functional magnetic resonance imaging methods to study cognitive and perceptual processing. Dr. Doniger’s doctoral work included seminal studies of object recognition from partial information in schizophrenia patients. Dr. Doniger holds a PhD in Experimental Psychology (2001) and an MA in Psychology (1999) from New York University and has served as a postdoctoral fellow at Princeton University. He is a former recipient of an NIMH individual predoctoral NRSA.
Director of Software Development
Mr. Amit joined NeuroTrax in 2001, and joined the management team in 2003. Mr. Amit is a specialist in software technologies involving the Internet and client applications. He has been instrumental in the design and implementation of the NeuroTrax technology platform and currently has primary responsibility for development and maintenance of the NeuroTrax technologies.
"It offers concrete data that can help identify which spheres of cognition are being affected."
“Allows easier access to cognitive assessments with good efficacy in a reasonable time frame."
“Longitudinal follow up with repeat testing sessions is also one of its strengths.”
“It's a peer-reviewed test that provides results that can be used to help improve care.”
“It allows for numeric and graphic comparisons both to 'normal' scores and also previous tests of same individual.”
“It lends the examiner credence when showing the results "in black and white.”
“Allows a more objective cognitive assessment and the results are often not obvious on interview.”
“This is a valuable tool that gives insight into current cognitive levels."
“Results are immediately available and the data can be instantly absorbed."
“People of a wide age range are able to perform this test with minimal to no computer knowledge.”
“… people appreciate having a time-efficient method of evaluating their cognition.”
“It's a convenient, on-site tool that provides a snapshot with a fair level of detail pertaining to one's cognitive abilities.”
“Provides a convenient, objective, cognitive assessment at low cost.”
“It is easy to use - it can be very time savvy”
“A more objective assessment of cognitive function”
“Good tool for establishing a baseline and tracking progress.”
“It creates an objective report.”
- First Ever Gene Linked to Better Cognitive Recovery After Mild Stroke Feb 21, 2019
- Stress is Associated with Brain Atrophy and Cognitive Decline in Stroke Survivors Sep 25, 2018
- Cardiovascular Health Predicts Cognitive Decline 2 Decades Later in Men with Preexisting Coronary Artery Disease Feb 15, 2018